cGMP Grade Cytokines & Growth Factors
The demand for Autologous and Allogeneic cell therapy is rapidly growing, thereby increasing the need for high quality raw material that can ensure maximum patient safety.
Proteintech GMP grade HumanKine growth factors and cytokines are produced in human cells, ensuring the right post-translational modifications required for the highest bioactivity. Our entire line of HumanKine products is exclusively manufactured using a human expression system, in accordance with USP and WHO standards, ensuring maximum safety and reproducibility.
-
ISO13485 certified
-
Raw material qualification
-
Quality check at every step of production
-
Animal component free and Xeno free production process
-
ISO rated clean rooms for manufacturing and filling
-
Regulatory support and Facilitiy available for on site audit
GMP Products
Why Choose HumanKine Cytokines & Growth Factors
- Protein is expressed in stable HEK293 systems with optimized yields.
- Safety, efficacy, and lot to lot consistency for therapeutic manufacturing.
- Robust scalability from preclinical to clinical and commercial quantities.
- Seamless transition from research to GMP grade.
cGMP Grade Cytokines and Growth Factors
All HumanKine cytokines and growth factors are expressed in HEK293 cells.
| Product | Activity (EC 50) | Purity |
|---|---|---|
| Activin A | 0.5-3.5 ng/mL | >95% |
| beta NGF | 0.5-3.0 ng/mL | >95% |
| BMP-2 | 7.5-37.5 ng/mL | >95% |
| BMP-4 | 1.5-9 ng/mL | >95% |
| BMP-7 | 50-275 ng/mL | >95% |
| Cystatin C | 0.5-2.6 µg/mL | >95% |
| EGF | 0.1-0.6 ng/mL | >95% |
| EPO | 0.2-3.0 ng/mL | >95% |
| FGF-4 | 6-30 ng/mL | >95% |
| FGF-7 (KGF) | 4-20 ng/mL | >95% |
| FGF-8b | 10-60 ng/mL EC50 | >95% |
| FGFbasic-TS | 0.4-2.5 ng/mL | >95% |
| FLT3 Ligand | 0.4-3.0 ng/mL | >95% |
| G-CSF | 0.009-0.05 ng/mL | >95% |
| GDNF | 3-18 ng/mL | >95% |
| GM-CSF | 0.08-0.8 ng/mL | >95% |
| HGF | 5-25 ng/mL | >95% |
| HGH | 0.05-0.5 ng/mL | >95% |
| HSA | N/A | >95% |
| IFN alpha 2B | 0.004-0.02 ng/mL | >95% |
| IFN beta | 0.015-0.08 ng/mL | > 95% |
| IFN gamma | 0.02-0.14 ng/mL | > 95% |
| IGF-I | 2-14 ng/mL | > 95% |
| IL-1 alpha | 0.125-1.25 ng/mL | >95% |
| IL-10 | 0.18-2.0 ng/mL | >95% |
| IL-12 | 0.8-4 ng/mL | >95% |
| IL-15 | 0.07-0.37 ng/mL | >95% |
| IL-2 | 0.05-0.35 ng/mL | >95% |
| IL-21 | 0.25-1.25 ng/mL | >95% |
| IL-28A | 0.01-0.06 ng/mL | >95% |
| IL-3 | 0.4-2.0 ng/mL | >95 % |
| IL-4 | 0.07-0.4 ng/mL | >95% |
| IL-6 | 0.03-0.24 ng/mL | >95% |
| IL-7 | 0.1-1.4 ng/mL | > 95% |
| IL-9 | 0.1-0.6 ng/mL | >95% |
| IL-34 | 0.45-4.5 ng/mL | >95% |
| LIF | 0.045-0.25 ng/mL | >95% |
| M-CSF | 0.7-4.0 ng/mL | >95% |
| Noggin | 1.5-15 ng/mL | >95% |
| OSM | 0.1-1.5 ng/mL | >95% |
| PDGFbb | 0.3-3 ng/mL | >95% |
| Pleiotrophin (PTN) | 100-500 ng/mL | > 95% |
| SCF | 15-85 ng/mL | >95% |
| TGF beta 1 | 0.01-0.17 ng/mL | >95% |
| TGF beta 2 | 0.018-0.18 ng/mL | >95% |
| TGF beta 3 | 0.01 - 0.2 ng/mL | > 95% |
| Thrombin | 1000-5000 units/mg | >95% |
| TNF alpha | 0.002-0.026 ng/mL | >95% |
| TPO (Thrombopoietin) | 100-500 ng/mL | >95% |
| Transferrin | 65-330 ng/mL | >95% |
| VEGF-C | 2-16 ng/mL | > 95% |
| VEGF121 | 1.5-9 ng/mL | >95% |
| VEGF165 | 0.3-3.75 ng/mL | >95% |
| Wnt3A | 25-500 ng/mL | >90% |
Talk to us about GMP proteins. Complete the form below for more information
Can't find your cGMP protein of interest?
Request for your cGMP protein of interest hereGMP Quality
Proteintech is ISO 13485:2016 certified and our GMP HumanKine products are manufactured and tested in accordance with the relevant sections of the following standards:
- USP Chapter <1043>, Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
- USP Chapter <92>, Growth Factors and Cytokines Used in Cell Therapy Manufacturing
- Ph. Eur. General Chapter 5.2.12, Raw Materials of Biological Origin for the Production of Cell-based and Gene Therapy Medicinal Products
- Sterility testing according to USP <71>.
- Mycoplasma testing according to USP<63>.
- Bacterial endotoxin test according to USP<85>.
GMP manufacturing process
RUO vs GMP
To facilitate a seamless preclinical to clinical transition, we offer both RUO and GMP grade cytokines and growth factors. Both product grades are produced under the same conditions in a GMP facility, using identical production processes. The GMP grade products come with extensive documentation, as well as thorough QC testing and traceability, whereas our line of RUO grade products are more cost-effective during early research and development.
Quality Features |
RUO |
GMP |
|---|---|---|
| Quality Management System: Manufactured, tested, released & distributed under ISO 13485 | ✔ | ✔ |
| Adherence to GMP guidelines | ✘ | ✔ |
| Master cell bank fully characterized | ✔ | ✔ |
| All processes according to released SOPs | ✔ | ✔ |
| Batch documentation | ✔ | ✔ |
| Change control, OOS and deviation procedures | ✔ | ✔ |
| Production and QC equipment qualified | ✔ | ✔ |
| Process validation by 3 consistency batches | ✘ | ✔ |
| Purity | > 95% | > 95% |
| Sterility testing USP<71> | ✘ | ✔ |
| Mycoplasma testing USP<63> | ✘ | ✔ |
| Endotoxin testing USP<85> | < 1.0 EU/µg | < 0.1 EU/µg |
| Validation of shelf life by accelerated and real-time testing | ✔ | ✔ |
| Identity of product confirmed | Two methods | Two methods |
| Supplier and raw material control | ✔ | ✔ |
| Activity value on CoA | EC50 | EC50 and specific activity (if NIBSC standard available) |
| Regulatory support: DMF, on-site audits, change notifications, quality agreements etc. | ✘ | ✔ (In progress) |
| View all HumanKine products | View all GMP HumanKine products |
Animal component and Xeno free
Driven by the desire for improved product consistency and safety of our products, we follow a strict Animal component-free (ACF) and Xeno-free policy. This policy ensures:
- The final product does not contain any constituent that is either an animal tissue, body fluid or components derived from it.
- All the materials, from procurement to final products, are stored and handled in a dedicated animal-free facility.
- The final product do not contain materials from non- human animal sources or recombinant materials made from non-human animal sources.
GMP Lot-to-lot Consistency
Consistency in raw material features is critical for efficient manufacturing of cell based therapies. A well-defined manufacturing process of HumanKine growth factors ensures high lot -to-lot consistency in its identity, purity and bioactivity.
GMP BMP-4 (HZ-1045-GMP)
Figure 1: Three independent lots of GMP BMP-4 were tested for their ability to induce alkaline phosphatase production in ATDC5 (mouse chondrogenic) cells. The EC50 for this assay is 1.5-9 ng/mL. The activity of each lot is nearly identical. Each lot was also analyzed for purity on an SDS-polyacrylamide gel under reducing and non-reducing conditions.
GMP PDGFbb (HZ-1308-GMP)
Figure 2: Three independent lots of GMP PDGFbb were tested for their ability to induce the proliferation of NIH/3T3 (mouse fibroblasts) cells. The EC50 for this assay is 0.3-3.0 ng/mL. The activity of each lot is nearly identical. Each lot was also analyzed for purity on an SDS-polyacrylamide gel. This data demonstrates the lot-to-lot consistency of this protein.
FAQs
- How are HumanKine GMP cytokines different from the RUO cytokines?
GMP proteins come with extensive documentation for traceability, as well as additional quality control testing and quality assurance reviews, whereas the RUO grade line offers reliable products which are more cost-effective during early research and development. As the manufacturing process is the same for RUO and GMP products, HumanKine offers a seamless preclinical-to-clinical transition line of products, saving a significant amount of time and money.
- Are HumanKine GMP cytokines suitable for direct human administration?
No, HumanKine GMP products are not intended to use as an excipient or therapeutic product that can be directly administered to the human body. These products are developed to be used as raw materials for the manufacturing of cell and gene therapy products, but not as part of the final formulation or therapy.
- Is HumanKine GMP product manufacturing certified by FDA or other regulatory agencies?
US-FDA does not audit or certify manufacturing facilities that produce ancillary materials. HumanKine GMP products are manufactured under the ISO13485 quality management system adhering to USP and European pharmacopeia recommendations to ensure potency, purity, and safety. The manufacturing facility can be audited by the end users upon request.
- What is the risk classification for HumanKine GMP Cytokines?
HumanKine GMP Cytokines are classified as Tier 2 risk products under USP Chapter <1043>. The products are low-risk, well-characterized materials, produced in compliance with GMP guidelines, and intended to be used as ancillary materials/raw materials.
- Are HumanKine GMP cytokines animal component free?
Yes! HumanKine GMP manufacturing processes and the final product do not use or contain any animal or human-derived components.
- How are HumanKine GMP cytokines shipped?
HumanKine GMP products are shipped as lyophilized, in glass vials at ambient temperature. The stability of these products is extensively tested to ensure the above-specified shipping conditions do not affect product quality or performance.
Documents
Documents available on request
- Certificate of Analysis (COA)
- Certificate of origin (COO)
- Sterility certificate
- BSE/TSE statement
- Viral testing certificate for Master cell bank
- Drug Master Files- filing in progress.
Please provide the following in the email:
- Your company name
- Product name and catalog number
- Document name
Proteintech's cGMP Facility in Chicago, IL
